Professor Julie Frearson, Ph.D.

Professor Julie Frearson, Ph.D.

Corporate Senior Vice President & Chief Scientific Officer

Julie Frearson, Ph.D. joined Charles River in 2014 and leads Charles River’s effort in developing and managing strategic technology partnerships, which are fundamental to the Company’s continued growth and future market leadership. She also plays a key role in the evaluation of Charles River’s strategic acquisitions.

Prof. Frearson has substantial experience in early-stage drug discovery, across multiple gene families and therapeutic areas, as a result of roles with The Babraham Institute (Cambridge, UK), Zeneca UK, Cambridge Drug Discovery, BioFocus, and a tenured faculty position in the Drug Discovery Unit of the University of Dundee. She has also served as Director for Scottish Universities Life Sciences Alliance (SULSA), and on Medical Research Council and Wellcome Trust expert committees. Prof. Frearson is author of more than 50 peer-reviewed publications.

Prof. Frearson received a Ph.D. in Biochemistry from King’s College London, University of London.

    Featured Report

    Charles River Corporate Citizenship Report
    View PDF
    Print PDF